During the last session, Hims & Hers Health Inc (NYSE:HIMS)’s traded shares were 14.98 million, with the beta value of the company hitting 1.07. At the end of the trading day, the stock’s price was $19.42, reflecting an intraday loss of -4.66% or -$0.95. The 52-week high for the HIMS share is $25.74, that puts it down -32.54 from that peak though still a striking 70.91% gain since the share price plummeted to a 52-week low of $5.65. The company’s market capitalization is $4.17B, and the average intraday trading volume over the past 10 days was 6.56 million shares, and the average trade volume was 10.68 million shares over the past three months.
Hims & Hers Health Inc (HIMS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.08. HIMS has a Sell rating from 0 analyst(s) out of 12 analysts who have looked at this stock. 5 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 6 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Hims & Hers Health Inc (NYSE:HIMS) trade information
Hims & Hers Health Inc (HIMS) registered a -4.66% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.66% in intraday trading to $19.42, hitting a weekly high. The stock’s 5-day price performance is -10.59%, and it has moved by -21.66% in 30 days. Based on these gigs, the overall price performance for the year is 118.45%. The short interest in Hims & Hers Health Inc (NYSE:HIMS) is 17.56 million shares and it means that shorts have 1.37 day(s) to cover.
The extremes of the forecast give a target low and a target high price of $5 and $24 respectively. As a result, HIMS is trading at a discount of -23.58% off the target high and 74.25% off the low.
Hims & Hers Health Inc (HIMS) estimates and forecasts
Statistics show that Hims & Hers Health Inc has outperformed its competitors in share price, compared to the industry in which it operates. Hims & Hers Health Inc (HIMS) shares have gone up 130.64% during the last six months, with a year-to-date growth rate more than the industry average at 281.82% against 18.60.
While earnings are projected to return 254.55% in 2024.
HIMS Dividends
Hims & Hers Health Inc is due to release its next quarterly earnings in August. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
The next largest institutional holding, with 10.86 million shares, is of BLACKROCK INC.’s that is approximately 5.1329% of outstanding shares. At the market price on 2024-03-31, these shares were valued at $168.01 million.